Recombinant influenza vectors with tandem transcription units

Details Recombinant influenza vectors with tandem transcription units Recombinant influenza vectors with tandem transcription units

2011-06-28

2011-06-28

Lucas, Zachariah (Department: 1648)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Virus or component thereof

C424S184100, C424S204100, C424S205100, C424S209100, C424S093600, C424S093200, C424S281100, C435S005000, C435S041000, C435S091330, C435S239000, C435S320100, C435S476000, C435S489000

Reexamination Certificate

active

07968101

ABSTRACT:
The invention provides a composition useful to prepare influenza viruses, e.g., in the absence of helper virus, using vectors which include tandem transcription cassettes containing PolI and/or PolII promoters.

REFERENCES:
patent: 4071618 (1978-01-01), Konobe et al.
patent: 4659569 (1987-04-01), Mitsuhashi et al.
patent: 5166057 (1992-11-01), Palese et al.
patent: 5578473 (1996-11-01), Palese et al.
patent: 5716821 (1998-02-01), Wertz et al.
patent: 5786199 (1998-07-01), Palese
patent: 5789229 (1998-08-01), Wertz et al.
patent: 5820871 (1998-10-01), Palese et al.
patent: 5840520 (1998-11-01), Clarke et al.
patent: 5854037 (1998-12-01), Palese et al.
patent: 6001634 (1999-12-01), Palese et al.
patent: 6033886 (2000-03-01), Conzelmann
patent: 6146642 (2000-11-01), Garcia-Sastre et al.
patent: 6271011 (2001-08-01), Lee et al.
patent: 6358733 (2002-03-01), Motwani et al.
patent: 6872395 (2005-03-01), Kawaoka
patent: 7226774 (2007-06-01), Kawaoka
patent: 2002/0164770 (2002-11-01), Hoffmann
patent: 2003/0035814 (2003-02-01), Kawaoka et al.
patent: 2004/0002061 (2004-01-01), Kawaoka
patent: 2004/0029251 (2004-02-01), Hoffman et al.
patent: 2004/0219170 (2004-11-01), Kawaoka
patent: 2004/0241139 (2004-12-01), Hobom et al.
patent: 2005/0037487 (2005-02-01), Kawaoka et al.
patent: 2006/0057116 (2006-03-01), Kawaoka et al.
patent: 2006/0134138 (2006-06-01), Kawaoka et al.
patent: 2006/0166321 (2006-07-01), Kawaoka et al.
patent: 2007/0141699 (2007-06-01), Kawaoka
patent: 0702085 (1996-03-01), None
patent: 0704533 (1996-04-01), None
patent: 1201760 (2002-05-01), None
patent: WO-98/02530 (1998-01-01), None
patent: WO-98/48834 (1998-11-01), None
patent: WO-98/53078 (1998-11-01), None
patent: WO-00/60050 (2000-10-01), None
patent: WO-01/79273 (2001-10-01), None
patent: WO-03/068923 (2003-08-01), None
patent: WO-2004/112831 (2004-12-01), None
patent: WO-2005/028658 (2005-03-01), None
patent: WO-2007/044024 (2007-04-01), None
Hoffmann et al., “Ambisense” Approach for the Generation of Influenza A Virus: vRNA and mRNA Synthesis from One Template, 2000, Virology, vol. 267, pp. 310-317.
Luytjes et al., Amplification, Expression, and Packaging of a Foreign Gene by Influenza Virus, 1989, Cell, vol. 59, pp. 1107-1113.
Saterlee, Production of H5N1 avian influenza virus vaccine by plasmid-based reverse genetics technology, 2008, Basic Biotechnology eJournal, vol. 4, pp. 93-98.
Result 17, NCBI Blast nucleotide search of SEQ ID No. 2, database “nr”, [on-line]. [retrieved on Jul. 18, 2006]. Retrieved from the Internet: <URL: http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi>, (2006), 3 pgs.
Result 7, NCBI Blast nucleotide search of SEQ ID: 1, database “nr”, [retrieved Jul. 18, 2006]. Retrieved from the Internet: <URL: http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi>, (2006) ,3 pgs.
Result 1, NCBI Blast nucleotide search of SEQ ID No. 3, database “nr”; Result 4, NCBI Blast nucleotide search of SEQ ID No. 4, “nr”, [retrieved Jul. 22, 2006], Retrieved from the Internet: <URL: http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi>, (2006), 11 pgs.
Result 2, NCBI Blast nucleotide search of SEQ ID No. 5, database “nr”; Result 4, NCBI Blast nucleotide search of SEQ ID No. 6, database “nr”, [retrieved Jul. 22, 2006], (2006), 6 pgs.
Results 1, NCBI Blast nucleotide search of SEQ ID No. 7, database “nr”; Result 1, NCBI Blast nucleotide search of SEQ ID No. 8, database “nr”, [retrieved Jul. 23, 2006], Retrieved from the Internet: <URL: http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi>, (2006), 8 pgs.
“Avian Influenza”,Queensland Government—Department of Primary Industries, [on-line]. [retrieved Feb. 22, 2003], <URL: http://www.dpi.qld.gov.au/health/3941.html>, (2003), 2 pgs.
“Avian Influenza”, [online]. [retrieved Feb. 22, 2003], <URL: http://www.iah.bbsrc.ac.uk/reports/1997/ainf.html>, (2003), 2 pgs.
“Confirmed Cases of Avian Influenza A(H5N1)”,World Health Organization, (Jan. 28, 2004),1 pg.
PCT Application No. PCT/US2005/041991, International Search Report mailed Jun. 4, 2007, 5 pgs.
“PCT Application No. PCT/US2005/041991, International Preliminary Report on Patentability / Written Opinion mailed Jul. 19, 2007”, 8 pgs.
“RNA World”, [online]. [retrieved Feb. 25, 2003]. Retrieved from the Internet: <URL: http://faculty.uca.edu/ ˜benw/biol4415/lecture10a/tsld003.htm>, (2003), 1 pg.
Banerjee, A. K., et al., “Gene Expression of Vesicular Stomatitis Virus Genome RNA.”,Virology, 188(2), (1992), 417-428.
Baron, M. D., et al., “Rescue of Rinderpest Virus From Cloned cDNA”,Journal of Virology, 71(2), (1997),1265-1271.
Beare, A. S., “Trials in Man With Live Recombinants Made from A/PR/8/34 (H0 N1) and Wild H3 N2 Influenza Viruses”,The Lancet, 2(7938), (1975),729-732.
Bilsel, P. , et al., “Mutations in the Cytoplasmic Tail of Influenza A Virus Neuraminidase Affect Incorporation into Virions”,Journal of Virology, 67(11), (Nov. 1993),6762-6767.
Blount, K. F., et al., “The Hammerhead Ribozyme”,Biochemical Society Transactions, 30(6), (2002),1119-1122.
Boyer, J.C., et al., “Infectious transcripts and cDNA clones of RNA viruses”,Virology, 198(2), (Feb. 1994),415-426.
Bradsher, K., “Cases of New Bird Flu in Hong Kong Prompt Worldwide Alerts”,The New York Times, (Feb. 22, 2003), 3 pgs.
Bradsher, K. , “Man's Death of ‘Bird Flu’ in Hong Kong Raises Fears”,The New York Times, (Feb. 22, 2003), 3 pgs.
Brands, R., et al., “Influvac: A Safe Madin Darby Canine Kidney (MDCK) Cell Culture-Based Influenza Vaccine”, (Abstract Only),Dev. Biol. Stand., 98, (1999), 93-100.
Bridgen, A. , “Rescue of a Segmented Negative-Strand RNA Virus Entirely From Cloned Complementary DNAs”,Proc. Natl. Acad. Sci. USA, 93, (1996),15400-15404.
Brühl, P., et al., “Humoral and Cell-Mediated Immunity to Vero Cell-Derived Influenza Vaccine”,Vaccine, 19, (2001),1149-1158.
Buchholz, U.J., et al., “Generation of Bovine Respiratory Syncytial Virus (BRSV) From cDNA: BRSV NS2 is Not Essentiial for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV Genome Promoter”,Journal of Virology, 73(1), (1999),251-259.
Bukreyev, A., et al., “Recovery of Infectious Respiratory Syncytial Virus Expressing an Additional, Foreign Gene”,Journal of Virology, 70(10), (Oct. 1996), 6634-6641.
Cardona, C. J., “Avian Influenza”, [online]. [retrieved Feb. 22, 2003]. Retrieved from the Internet: <URL: http://www.vetmed.ucdavis.edu/vetex/INF-PO—AvianInfluenzaFS.html, (2003), 3 pgs.
Castrucci, M. R., “Attenuation of Influenza a Vuris by Insertion of a Foreign Epitope into the Neuraminidase”,Journal of Virology, 66(8), (Aug. 1992), 4647-4653.
Castrucci, M. R., et al., “Biologic Importance of Neuraminidase Stalk Length in Influenza A Virus”,Journal of Virology, Feb. 1993, vol. 67, No. 2, (Oct. 22, 1992),759-764.
Castrucci, M. R., et al., “Protection against Lethal Lymphocytic Choriomeningitis Virus (LCMV) Infection by Immunization of Mice with an Influenza Virus Containing an LCMV Epitope Recognized by Cytotoxic T Lymphocytes”,Journal of Virology, vol. 68(6), (Jun. 1994),3486-3490.
Castrucci, M. , “Reverse Genetics System for Generation of an Influenza A Virus Mutant Containing a Deletion of the Carboxyl-Terminal Residue of M2 protein”,Journal of Virology, 69(5), (May 1995),2725-2728.
Chen, Z., et al., “Influenza A Virus NS1 Protein Targets Poly(A)-Binding Protein II of the Cellular 3′-End Processing Machinery”,The EMBO Journal, 18(8), (1999),2273-2283.
Chowrira, B. M., et al., “In Vitro and in Vivo Comparison of Hammerhead, Hairpin, and Hepatitis Delta Virus Self-Processing Ribozyme Cassettes”,Th

Affiliated with

Also associated with

Rating

Recombinant influenza vectors with tandem transcription units does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant influenza vectors with tandem transcription units, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant influenza vectors with tandem transcription units will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2703289